Form 4: McKesson Executive Sells Over 1,000 Shares Following RSU Vesting

A McKesson Corp. senior executive, Napoleon B. Rutledge JR, SVP, Controller & CAO, reported the sale of 1,049 shares of common stock following the vesting of Restricted Stock Units (RSUs) and tax withholding, as part of a pre-arranged 10b5-1 trading plan.

Summary

• Napoleon B. Rutledge JR, SVP, Controller & CAO of McKesson Corp. (MCK), reported transactions on May 23, 2025, and May 27, 2025.
• On May 23, 2025, 136 shares of common stock were acquired at a price of $0, stemming from the vesting of Restricted Stock Units (RSUs).
• Concurrently on May 23, 2025, 41 shares were disposed of at $716.09 to cover taxes related to the RSU vesting.
• An additional 63 shares were sold on May 23, 2025, at $715.24 per share.
• On May 27, 2025, 986 shares were sold at $714.30 per share.
• Both sales on May 23 and May 27 were conducted pursuant to a Rule 10b5-1(c) plan adopted on February 7, 2025.
• Following these transactions, Mr. Rutledge's direct beneficial ownership of McKesson common stock decreased from 2,171 shares to 1,081 shares.
• The RSUs vested as to 1/3 on May 23, 2024, 1/3 on May 23, 2025, and will vest 1/3 on May 23, 2026.

Sentiment

Score: 4

Explanation: The sentiment is slightly negative due to a net decrease in insider holdings, although the sales were pre-planned under a 10b5-1 plan, which mitigates the negative perception compared to unplanned sales.

Positives

• The vesting of Restricted Stock Units (RSUs) indicates a component of executive compensation, aligning management interests with shareholder value over time.

Negatives

• The executive's beneficial ownership of common stock decreased by 954 shares (136 acquired 41 tax 63 sale 986 sale) as a result of these transactions, representing a net reduction in insider holdings.

Risks

• While the sales were pre-planned under a 10b5-1 plan, a net reduction in insider ownership could be perceived by some investors as a lack of confidence, though it is a common practice for executives to diversify their holdings.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook, beyond the scheduled future vesting of RSUs on May 23, 2026.

Industry Context

This filing is a routine insider transaction report and does not provide specific insights into broader industry trends or competitive dynamics within the healthcare distribution sector. Executive stock sales, particularly those under 10b5-1 plans, are common for diversification and liquidity purposes.

Stakeholder Impact

• Shareholders: May view the net reduction in insider ownership as a minor negative signal, though the pre-planned nature of the sales (10b5-1 plan) suggests routine diversification rather than a lack of confidence in the company's future.

Next Steps

• The remaining 1/3 of the Restricted Stock Units (RSUs) held by the reporting person are scheduled to vest on May 23, 2026.

Key Dates

Keywords

McKesson, MCK, Form 4, insider trading, stock sale, Restricted Stock Units, RSU vesting, executive compensation, 10b5-1 plan, beneficial ownership